Radiometer has confirmed the completion of its takeover of HemoCue, as originally announced in February 2013.
HemoCue - a developer of point-of-care testing solutions headquartered in Sweden - has now become a Danaher company, but will continue to operate as a separate brand and organisation, with its management and channel structure remaining intact.
As both Radiometer and HemoCue are leaders in their respective fields of point-of-care and near-patient testing, the acquisition will offer a number of synergistic benefits, accelerating growth and innovation for both firms.
The deal for HemoCue - which employs around 500 people worldwide and was responsible for the creation of the first system for accurate haemoglobin testing in near-patient settings back in 1982 - was valued at $300 million (196.64 million pounds).
Peter Kurstein, president of Radiometer, said: "I expect that we will strengthen our offerings to supply healthcare providers around the globe with even broader and stronger solutions to their point-of-care testing."See all the latest jobs in Science